Lakefront Biotherapeutics · EURONEXT:LKFT

Gilead Sciences, Inc. reported a 29.90% stake in Lakefront Biotherapeutics (Schedule 13D/A)

Event Jan 7, 2025 · Filed Jan 10, 2025

Gilead Sciences, Inc. reported a 29.90% stake in Lakefront Biotherapeutics, 20,981,010 shares, with active intent on Jan 7, 2025. Filed Jan 10, 2025 (Schedule 13D/A).

Stake
29.90%
Shares
20,981,010
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Gilead Sciences, Inc.29.90%20,981,010
Gilead Therapeutics A1 Unlimited Company29.90%20,981,010

Source

View original at SEC

Related